Found 0 matching trials
Study of Durvalumab in Combination With Platinum and Etoposide for the First Line Treatment of Patients With Extensive-stage Small Cell Lung Cancer
PHASE3Study to determine the safety and tolerability profile of durvalumab with p...
Phase II Study of Orelabrutinib Combined With PD-1 Inhibitor in Relapsed/Refractory Primary Central Nervous System Lymphoma
PHASE2This is a prospective multicenter single-arm phase II study, and the purpos...
SBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases
PHASE3To explore the efficacy and safety of stereotactic body radiation therapy (...
Location
Sixth Affiliated Hospital, Sun Yat-sen University
Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial
PHASE3This is a multicenter, open-label, randomized, controlled, phase III trial....
Location
Sun Yat-sen University Cancer Center
Lenvatinib Plus PD-1 Antibody for Intermediate-stage HCC Beyond Up-to-seven Criteria
PHASE2The purpose of this study is to evaluate the efficacy and safety of lenvati...
Location
Cancer Center Sun Yat-sen University
Immediate Versus Postponed Single Blastocyst Transfer in Programmed or Stimulated Cycle Frozen Embryo Transfer
NAThe aim of this randomized controlled trial is to examine whether single bl...
Location
Fertility Departmen, Rigshospitalet
Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma
PHASE2MARIO-3 is a Phase 2 multi-arm combination cohort study designed to evaluat...
Location
Ironwood Cancer and Research Center
Pembrolizumab With Carboplatin Compared to Carboplatin Alone in Breast Cancer Patients With Chest Wall Disease
PHASE2This is a phase II multicenter study including breast cancer patients with ...
Location
University of California, San Francisco
Pembrolizumab + Poly-ICLC in MRP Colon Cancer
PHASE1The main purpose of this study is to determine the dose of poly-ICLC that i...
Location
Georgia Cancer Center at Augusta University
PD1 Antibody and Lenalidomide as a Treatment for EBV-HLH or CAEBV
PHASE3The present study was a prospective one-arm clinical study, in which EBV-HL...
Location
Beijing Friendship Hospital, Capital Medical University